Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.

Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DG.

PLoS One. 2011;6(9):e24397. doi: 10.1371/journal.pone.0024397. Epub 2011 Sep 15.

PMID:
21935404
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28.

PMID:
22740085
[PubMed - indexed for MEDLINE]
3.

Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.

Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L, Yang Z, Xia Z.

Int J Biol Sci. 2013 May 15;9(5):472-9. doi: 10.7150/ijbs.5855. Print 2013.

PMID:
23781140
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?

Wei C, Guomin W, Yujun L, Ruizhe Q.

Cancer Biol Ther. 2007 May;6(5):763-8. Epub 2007 Feb 8.

PMID:
17592251
[PubMed - indexed for MEDLINE]
Free Article
5.

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.

Cheng W, Liu T, Wan X, Gao Y, Wang H.

FEBS J. 2012 Jun;279(11):2047-59. doi: 10.1111/j.1742-4658.2012.08589.x. Epub 2012 Apr 24.

PMID:
22498306
[PubMed - indexed for MEDLINE]
6.

Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Zhang L, Jiao M, Li L, Wu D, Wu K, Li X, Zhu G, Dang Q, Wang X, Hsieh JT, He D.

J Cancer Res Clin Oncol. 2012 Apr;138(4):675-86. doi: 10.1007/s00432-011-1146-2. Epub 2012 Jan 12.

PMID:
22237455
[PubMed - indexed for MEDLINE]
7.

Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.

Ohata H, Ishiguro T, Aihara Y, Sato A, Sakai H, Sekine S, Taniguchi H, Akasu T, Fujita S, Nakagama H, Okamoto K.

Cancer Res. 2012 Oct 1;72(19):5101-10. doi: 10.1158/0008-5472.CAN-11-3812. Epub 2012 Sep 20.

PMID:
23002207
[PubMed - indexed for MEDLINE]
Free Article
8.

Identification of gastric cancer stem cells using the cell surface marker CD44.

Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC.

Stem Cells. 2009 May;27(5):1006-20. doi: 10.1002/stem.30.

PMID:
19415765
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.

Chen J, Wang J, Chen D, Yang J, Yang C, Zhang Y, Zhang H, Dou J.

BMC Cell Biol. 2013 Jan 31;14:7. doi: 10.1186/1471-2121-14-7.

PMID:
23368632
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ.

Chen HC, Chou AS, Liu YC, Hsieh CH, Kang CC, Pang ST, Yeh CT, Liu HP, Liao SK.

Lab Invest. 2011 Oct;91(10):1502-13. doi: 10.1038/labinvest.2011.91. Epub 2011 Jun 20.

PMID:
21691263
[PubMed - indexed for MEDLINE]
Free Article
11.

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells.

Liu J, Xiao Z, Wong SK, Tin VP, Ho KY, Wang J, Sham MH, Wong MP.

Oncotarget. 2013 Oct;4(10):1698-1711.

PMID:
24091605
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.

Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL.

Clin Exp Metastasis. 2009;26(5):433-46. doi: 10.1007/s10585-009-9242-2. Epub 2009 Feb 17.

PMID:
19221883
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.

Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, Johnson F, Golub LM, Zhang Y, Ojima I, Shroyer KR.

PLoS One. 2013 Sep 24;8(9):e69884. doi: 10.1371/journal.pone.0069884. eCollection 2013.

PMID:
24086245
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.

Rao GH, Liu HM, Li BW, Hao JJ, Yang YL, Wang MR, Wang XH, Wang J, Jin HJ, Du L, Chen Q.

Acta Pharmacol Sin. 2013 Jun;34(6):793-804. doi: 10.1038/aps.2013.56.

PMID:
23736004
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.

Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7. Epub 2011 Jul 13.

PMID:
21750907
[PubMed - indexed for MEDLINE]
16.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

PMID:
19451087
[PubMed - indexed for MEDLINE]
Free Article
17.

CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma.

Janisiewicz AM, Shin JH, Murillo-Sauca O, Kwok S, Le QT, Kong C, Kaplan MJ, Sunwoo JB.

Int Forum Allergy Rhinol. 2012 Nov;2(6):465-70. doi: 10.1002/alr.21068. Epub 2012 Aug 7.

PMID:
22887934
[PubMed - indexed for MEDLINE]
18.

CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R.

Cancer Biol Ther. 2010 Dec 1;10(11):1182-90. Epub 2010 Dec 1.

PMID:
20948317
[PubMed - indexed for MEDLINE]
Free Article
19.

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, Ferrini S, Chouaib S, Vazquez A, Charpentier B, Camussi G, Azzarone B, Eid P.

J Natl Cancer Inst. 2011 Dec 21;103(24):1884-98. doi: 10.1093/jnci/djr451. Epub 2011 Oct 31.

PMID:
22043039
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

Reim F, Dombrowski Y, Ritter C, Buttmann M, Häusler S, Ossadnik M, Krockenberger M, Beier D, Beier CP, Dietl J, Becker JC, Hönig A, Wischhusen J.

Cancer Res. 2009 Oct 15;69(20):8058-66. doi: 10.1158/0008-5472.CAN-09-0834. Epub 2009 Oct 13.

PMID:
19826050
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk